INVESTORS IN LIFE SCIENCES

The Bio/Med Investor Network was established in 2014 to address the need to connect early-stage biomedical, medtech and healthcare-related companies with angel investors interested in advancing technologies in this innovative industry. The majority of our investors specialize in life sciences, and include active and retired executives, practicing physicians, and scientists. Their unique qualifications guide screening and due diligence to help fellow members choose their investments.

 

INVESTMENT PORTFOLIO

Partners. Visionaries.

NeocisLogo.png

NEOCIS

Neocis is the world leader in robotic guided dentistry. The Neocis team is comprised of roboticists, engineers, and doctors with a successful history of commercializing medical robotics.
Miami, FL

unnamed.jpg

ACCUITIS

Accuitis, Inc. is engaged in the acquisition and development ofpharmaceuticals targeting niche, orphan, and underserved disease states.
Atlanta, GA

nfant.png

NFANT LABS

NFANT Labs is a medical device and digital health company dedicated to improving the standard of care in infant feeding by providing medical products and services without prohibitive cost.
Atlanta, GA

OCUCURE

OcuCure is an ophthalmic pharmaceutical company developing new proprietary compounds with a focus on topical eye drops.
Roanoke, VA

MANA HEALTH

Mana Health is dedicated to streamlining data access, interoperability, and innovation in healthcare.
New York, NY

FORTUS

Fortus' proprietary technology is used to harvest a patient's own mesenchymal stem cells (MSCs) leaving a highly concentrated stem cell solution, which is combined with bone graft material to repair and promote new bone growth in a patient.
Minneapolis, MN

curvafixlogo.png

CURVAFIX

CurvaFix® produces the only implant capable of following natural bone curvature to fill space within the bone enabling a quicker recovery, less invasive procedure and shorter surgery for pelvic fracture patients in a >$600M global market.
Seattle, WA

cathaid_logo.png

CATHAID

Cathaid seamlessly replaces the flawed standard of care with one simple to use device. Cathaid gives clinicians the ability to detect positional shifts, secure the catheter, and provides a full medical seal around the entry site.
Evans, GA

 

CONTACT

c/o Erris Consulting Group
1201 Peachtree St. NE, Suite 300 | Atlanta, GA 30361

404-953-5255

Coins
 

©2020 Bio/Med Investor Network